Fengjuan B. Jiang

Tianjin Key Laboratory Of Bone Marrow Failure And Malignant Hemopoietic Clone Control, State Key Laboratory Of Experimental Hematology
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Microvesicles derived from bone marrow and peripheral blood can reflect tumor load in multiple myeloma.

Microvesicles derived from bone marrow and peripheral blood can reflect tumor load in multiple myeloma.

Journal: Journal of translational internal medicine

Published: February 23, 2026

Correction: Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.

Correction: Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.

Journal: Journal of translational medicine

Published: November 22, 2025

Kaempferol induces mitophagy and disrupts iron metabolism via SFXN2 leading to apoptosis in multiple myeloma cells.

Kaempferol induces mitophagy and disrupts iron metabolism via SFXN2 leading to apoptosis in multiple myeloma cells.

Journal: Free radical biology & medicine

Published: April 28, 2025

T-lymphocytes suppression by CD14+ monocytes with high expression of ULK2 in patients with multiple myeloma.

T-lymphocytes suppression by CD14+ monocytes with high expression of ULK2 in patients with multiple myeloma.

Journal: Journal of translational medicine

Published: March 18, 2025

Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.

Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.

Journal: Journal of translational medicine

Published: January 16, 2025

The academic sources of You Ke Tie Jing

The academic sources of You Ke Tie Jing

Journal: Zhonghua yi shi za zhi (Beijing, China : 1980)

Published: May 16, 2022

Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease.

Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Published: January 06, 2022

Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.

Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.

Journal: Cancer biology & medicine

Published: May 07, 2021

Effect factors related to a high probability of hemodialysis independence in newly diagnosed multiple myeloma patients requiring hemodialysis.

Effect factors related to a high probability of hemodialysis independence in newly diagnosed multiple myeloma patients requiring hemodialysis.

Journal: Journal of clinical laboratory analysis

Published: July 25, 2019

CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease.

CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease.

Journal: Cancer medicine

Published: May 20, 2019

Involvement of MM cell-derived exosomes in T lymphocytes immune responses.

Involvement of MM cell-derived exosomes in T lymphocytes immune responses.

Journal: Oncology letters

Published: May 12, 2019

The Effect and Safety of Bortezomib in the Treatment of AL Amyloidosis: A Systematic Review and Meta-Analysis.

The Effect and Safety of Bortezomib in the Treatment of AL Amyloidosis: A Systematic Review and Meta-Analysis.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: September 26, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026